Cara Therapeutics | CARA - Trade Creditors


Cara Therapeutics reported $4.62M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Cassava Sciences USD 39.19M 2.46M Mar/2026
Chugai Pharma JPY 160.7B 53.18B Jun/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.53M 173K Mar/2026
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 14.1M 6.8M Mar/2026
J&J USD 9.22B 1.24B Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Pacira USD 17.51M 3.5M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
RedHill Biopharma USD 731K 104K Dec/2025
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024